Selma Diagnostics ApS: Financial statements 2022
CVR: 36961376
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,636,197 and a net result of DKK -2,768,328 compared with DKK -1,953,914 the year before. Equity in the 2022 report amounted to DKK -3,988,932. The company had 2 employees in the financial year.
- Gross Profit
- DKK -1,636,197
- Profit/Loss
- DKK -2,768,328
- Equity
- DKK -3,988,932
- Total Assets
- DKK 516,034
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1.6 mio. | -2.8 mio. | -4 mio. | 2 |
| 2021 | - | -1.8 mio. | -2 mio. | -1.2 mio. | 2 |
| 2020 | - | -1.6 mio. | -2.4 mio. | 733 t. | 3 |
| 2019 | - | -1.9 mio. | -2.7 mio. | 415 t. | 3 |
| 2018 | - | -1.7 mio. | -2.6 mio. | 1.5 mio. | 3 |
Official annual report
Keep an eye on Selma Diagnostics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Selma Diagnostics ApS has published its annual report for 2021. Gross profit came to DKK -1,844,276, and the net result was DKK -1,953,914.
About Selma Diagnostics ApS
Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The board consists of Carsten Krogh Gomard (chair), Andreas Hjarne Kunding and John Alexander. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity in the 2025 report amounted to DKK -11,154,823.